DCF — UH CLEVELAND MEDICAL CENTER
Enterprise Value: $-2.0B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.0B
Enterprise Value
$-653.4M
PV of Cash Flows
$-1.3B
PV of Terminal Value
$-2.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $2.3B | $-102.2M | -4.0% | $-198.8M | $-180.7M |
| Year 2 | $2.4B | $-81.7M | -3.0% | $-181.2M | $-149.8M |
| Year 3 | $2.4B | $-60.0M | -2.0% | $-162.5M | $-122.1M |
| Year 4 | $2.5B | $-49.3M | -2.0% | $-154.9M | $-105.8M |
| Year 5 | $2.6B | $-44.4M | -2.0% | $-153.1M | $-95.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.0B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$2.2B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.049766578932743645
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5